Michael Goller is listed as a director on 2 SEC Form D filings by 2 issuers between Jun 2010 and Apr 2026: Terremoto Biosciences, Inc. (South San Francisco, CA — biotechnology — 2026; $40.7M reported sold to 14 investors) and DIADEXUS INC (South San Francisco, CA — biotechnology — 2010; $4.5M reported sold to 11 investors).
What this means 2 separate companies raised money with this person listed as director, over about 16 years. Across those companies the filings report $45.2M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 court cases matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Michael Goller and found 3 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Michael Goller" (NY) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.